| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.85B | -64.4% |
| Cost of Revenue | $4.69B | -13.3% |
| R&D Expense | $4.84B | +47.0% |
| SG&A Expense | $1.55B | +36.8% |
| Operating Income | -$4.24B | -145.0% |
| Pre-tax Income | -$3.94B | -141.2% |
| Income Tax | $772.0M | -36.4% |
| Net Income | -$4.71B | -156.4% |
| EPS (Basic) | -$12.33 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.91B | -9.3% |
| Accounts Receivable | $892.0M | -35.6% |
| Inventory | $202.0M | -78.7% |
| Current Assets | $10.32B | -23.1% |
| Total Assets | $18.43B | -28.7% |
| Current Liabilities | $3.02B | -38.8% |
| Total Liabilities | $4.57B | -32.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.12B | -162.6% |
| Capital Expenditures | $707.0M | +76.8% |
| Investing Cash Flow | $4.21B | +181.3% |
| Financing Cash Flow | -$1.38B | +60.1% |
| Free Cash Flow | -$3.83B | -183.5% |
| -158.0% |
| EPS (Diluted) | -$12.33 | -161.3% |
| Stockholders' Equity |
| $13.85B |
| -27.6% |